Simplex Trading’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Sell
6,700
-30,100
-82% -$574K ﹤0.01% 4862
2025
Q4
$800K Buy
36,800
+14,800
+67% +$424K ﹤0.01% 2841
2025
Q3
$717K Buy
22,000
+2,100
+11% +$77.5K ﹤0.01% 3390
2025
Q2
$706K Buy
19,900
+3,600
+22% +$117K ﹤0.01% 3155
2025
Q1
$553K Sell
16,300
-10,500
-39% -$377K ﹤0.01% 3306
2024
Q4
$872K Buy
26,800
+5,400
+25% +$224K ﹤0.01% 2980
2024
Q3
$1.04M Sell
21,400
-10,200
-32% -$543K ﹤0.01% 2873
2024
Q2
$1.4M Sell
31,600
-12,000
-28% -$554K ﹤0.01% 2560
2024
Q1
$2.44M Buy
43,600
+37,300
+592% +$2.25M ﹤0.01% 2202
2023
Q4
$379K Buy
6,300
+3,400
+117% +$215K ﹤0.01% 3983
2023
Q3
$194K Sell
2,900
-400
-12% -$27.8K ﹤0.01% 4385
2023
Q2
$227K Buy
3,300
+1,400
+74% +$91.5K ﹤0.01% 4162
2023
Q1
$91K Sell
1,900
-3,300
-63% -$161K ﹤0.01% 5255
2022
Q4
$259K Buy
5,200
+400
+8% +$19.4K ﹤0.01% 3908
2022
Q3
$195K Sell
4,800
-8,100
-63% -$380K ﹤0.01% 4642
2022
Q2
$709K Sell
12,900
-12,200
-49% -$515K ﹤0.01% 3022
2022
Q1
$912K Buy
25,100
+21,800
+661% +$861K ﹤0.01% 3026
2021
Q4
$153K Buy
3,300
+1,900
+136% +$96.4K ﹤0.01% 5570
2021
Q3
$58K Hold
1,400
﹤0.01% 7340
2021
Q2
$57K Buy
1,400
+1,398
+69,900% +$47.5K ﹤0.01% 7483
2021
Q1
$5K Buy
+2
New +$55 ﹤0.01% 8211

Other funds holding LEGN

Simplex Trading's LEGN Position: Q1 2026 in Review

Simplex Trading sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 29,432 shares — an estimated $561K sold.

Simplex Trading first reported a position in LEGN in Q1 2021 and held it in 10 quarters. The position peaked at $640K in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Simplex Trading reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 29,432 Legend Biotech shares in Q1 2026, an estimated $561K.
  • Simplex Trading first reported a position in Legend Biotech in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's Legend Biotech position peaked at $640K in Q4 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.